In the early 2000s, Paul Harris, a research informatics faculty member and bioengineer at Vanderbilt University Medical Center, noticed a pressing problem. While working with research teams, he found ...
New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures The research assesses how protocol design ...
Please provide your email address to receive an email when new articles are posted on . Creators of the OpenEvidence AI data aggregation tool have partnered with the New England Journal of Medicine to ...
“End-to-End” Strategies Achieve Better Enrollment, Diversity, and Data Collection in Clinical Trials
The revolution in cancer drug development has a caveat: Only a fraction of eligible patients take part in clinical trials. Historically, findings from studies estimate that the share of eligible ...
Serious Games for Serious Pain: Development and Initial Testing of a Cognitive Behavioral Therapy Game for Patients With Advanced Cancer Pain Longitudinal patient tolerability data collected as part ...
Decentralized Clinical Trials Market OverviewThe global decentralized clinical trials (DCTs) market is witnessing strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results